Literature DB >> 35045266

An ESCRT/VPS4 Envelopment Trap To Examine the Mechanism of Alphaherpesvirus Assembly and Transport in Neurons.

Jenna Barnes1, Bryen A Jordan2, Duncan W Wilson1,2.   

Abstract

The assembly and egress of alphaherpesviruses, including herpes simplex virus 1 (HSV-1) and pseudorabies virus (PRV), within neurons is poorly understood. A key unresolved question is the structure of the viral particle that moves by anterograde transport along the axon, and two alternative mechanisms have been described. In the "married" model, capsids acquire their envelopes in the cell body and then traffic along axons as enveloped virions within a bounding organelle. In the "separate" model, nonenveloped capsids travel from the cell body into and along the axon, eventually encountering their envelopment organelles at a distal site, such as the nerve cell terminal. Here, we describe an "envelopment trap" to test these models using the dominant negative terminal endosomal sorting complex required for transport (ESCRT) component VPS4-EQ. Green fluorescent protein (GFP)-tagged VPS4-EQ was used to arrest HSV-1 or PRV capsid envelopment, inhibit downstream trafficking, and GFP-label envelopment intermediates. We found that GFP-VPS4-EQ inhibited trafficking of HSV-1 capsids into and along the neurites and axons of mouse CAD cells and rat embryonic primary cortical neurons, consistent with egress via the married pathway. In contrast, transport of HSV-1 capsids was unaffected in the neurites of human SK-N-SH neuroblastoma cells, consistent with the separate mechanism. Unexpectedly, PRV (generally thought to utilize the married pathway) also appeared to employ the separate mechanism in SK-N-SH cells. We propose that apparent differences in the methods of HSV-1 and PRV egress are more likely a reflection of the host neuron in which transport is studied rather than true biological differences between the viruses themselves. IMPORTANCE Alphaherpesviruses, including herpes simplex virus 1 (HSV-1) and pseudorabies virus (PRV), are pathogens of the nervous system. They replicate in the nerve cell body and then travel great distances along axons to reach nerve termini and spread to adjacent epithelial cells; however, key aspects of how these viruses travel along axons remain controversial. Here, we test two alternative mechanisms for transport, the married and separate models, by blocking envelope assembly, a critical step in viral egress. When we arrest formation of the viral envelope using a mutated component of the cellular ESCRT apparatus, we find that entry of viral particles into axons is blocked in some types of neurons but not others. This approach allows us to determine whether envelope assembly occurs prior to entry of viruses into axons or afterwards and, thus, to distinguish between the alternative models for viral transport.

Entities:  

Keywords:  ESCRT; HSV-1; PRV; anterograde transport; envelopment; neuronal egress

Mesh:

Substances:

Year:  2022        PMID: 35045266      PMCID: PMC8941884          DOI: 10.1128/jvi.02178-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  83 in total

1.  Structural basis of membrane budding by the nuclear egress complex of herpesviruses.

Authors:  Janna M Bigalke; Ekaterina E Heldwein
Journal:  EMBO J       Date:  2015-10-28       Impact factor: 11.598

2.  Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding.

Authors:  Gwen M Taylor; Phyllis I Hanson; Margaret Kielian
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

3.  Characterization of herpes simplex virus-containing organelles by subcellular fractionation: role for organelle acidification in assembly of infectious particles.

Authors:  C A Harley; A Dasgupta; D W Wilson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  MAP2 Defines a Pre-axonal Filtering Zone to Regulate KIF1- versus KIF5-Dependent Cargo Transport in Sensory Neurons.

Authors:  Laura F Gumy; Eugene A Katrukha; Ilya Grigoriev; Dick Jaarsma; Lukas C Kapitein; Anna Akhmanova; Casper C Hoogenraad
Journal:  Neuron       Date:  2017-04-19       Impact factor: 17.173

Review 5.  Structures, Functions, and Dynamics of ESCRT-III/Vps4 Membrane Remodeling and Fission Complexes.

Authors:  John McCullough; Adam Frost; Wesley I Sundquist
Journal:  Annu Rev Cell Dev Biol       Date:  2018-08-10       Impact factor: 13.827

Review 6.  Cellular Functions and Molecular Mechanisms of the ESCRT Membrane-Scission Machinery.

Authors:  Liliane Christ; Camilla Raiborg; Eva M Wenzel; Coen Campsteijn; Harald Stenmark
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

7.  Fusion of a fluorescent protein to the pUL25 minor capsid protein of pseudorabies virus allows live-cell capsid imaging with negligible impact on infection.

Authors:  Kevin P Bohannon; Patricia J Sollars; Gary E Pickard; Gregory A Smith
Journal:  J Gen Virol       Date:  2011-10-05       Impact factor: 3.891

8.  Structure and membrane remodeling activity of ESCRT-III helical polymers.

Authors:  John McCullough; Amy K Clippinger; Nathaniel Talledge; Michael L Skowyra; Marissa G Saunders; Teresa V Naismith; Leremy A Colf; Pavel Afonine; Christopher Arthur; Wesley I Sundquist; Phyllis I Hanson; Adam Frost
Journal:  Science       Date:  2015-12-03       Impact factor: 47.728

9.  ESCRT-III mediates budding across the inner nuclear membrane and regulates its integrity.

Authors:  Jun Arii; Mizuki Watanabe; Fumio Maeda; Noriko Tokai-Nishizumi; Takahiro Chihara; Masayuki Miura; Yuhei Maruzuru; Naoto Koyanagi; Akihisa Kato; Yasushi Kawaguchi
Journal:  Nat Commun       Date:  2018-08-23       Impact factor: 14.919

10.  Insights into herpesvirus assembly from the structure of the pUL7:pUL51 complex.

Authors:  Benjamin G Butt; Danielle J Owen; Cy M Jeffries; Lyudmila Ivanova; Chris H Hill; Jack W Houghton; Md Firoz Ahmed; Robin Antrobus; Dmitri I Svergun; John J Welch; Colin M Crump; Stephen C Graham
Journal:  Elife       Date:  2020-05-11       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.